卡森國際(0496.HK)暴跌90%後緊急停牌 遭Blue Orca做空
格隆匯11月21日丨卡森國際(0496.HK)緊急停牌,停牌前暴跌90.07%,報0.455港元,創10年新低,成交8289萬港元,最新總市值6.8億港元。

沽空機構Blue Orca今日發報告稱由於對柬埔寨業務和資本支出的擔憂而做空該公司股票。Blue Orca稱,卡森國際董事長及其家族通過人為低報出售業務的收入和利潤,矇騙投資者洗劫了上市公司。該機構表示,一家虛報資本支出,還讓董事長家族拿走上市主體最有價值業務的公司,完全不值得投資,同時還指出其柬埔寨發展項目現址僅為一塊空地,業權已為他人所有。
Blue Orca認為卡森國際股價只值0.67港元,有85%的下跌空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.